Cargando…
An overview on prostate-specific membrane antigen uptake in malignancies other than prostate cancer: A pictorial essay
Prostate-specific membrane antigen (PSMA) is a Type II transmembrane glycoprotein which is extremely overexpressed in prostate cancer epithelial cells. Recently, PSMA-targeted small molecule labeled with (68)Ga and (99m)Tc allowed precise molecular imaging of prostate cancer and PSMA-targeted small...
Autores principales: | Jafari, Esmail, Ahmadzadehfar, Hojjat, Dadgar, Habibollah, Assadi, Majid |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7745855/ https://www.ncbi.nlm.nih.gov/pubmed/33354182 http://dx.doi.org/10.4103/wjnm.WJNM_78_19 |
Ejemplares similares
-
Potential application of lutetium-177-labeled prostate-specific membrane antigen-617 radioligand therapy for metastatic castration-resistant prostate cancer in a limited resource environment: Initial clinical experience after 2 years
por: Assadi, Majid, et al.
Publicado: (2020) -
Quality control and GMP synthesis of (68)Ga-prostate-specific membrane antigen-11 for detection of low- and high-grade prostate cancer
por: Assadi, Majid, et al.
Publicado: (2019) -
(177)Lu-DOTATATE and (177)Lu-prostate-specific membrane antigen therapy in a patient with advanced metastatic radioiodine-refractory differentiated thyroid cancer after failure of tyrosine kinase inhibitors treatment
por: Assadi, Majid, et al.
Publicado: (2019) -
Peptide Receptor Radionuclide Therapy with (177)Lu-DOTATATE in a Case of Concurrent Neuroendocrine Tumors and Meningioma: Achieving Two Things in a Single Action
por: Assadi, Majid, et al.
Publicado: (2021) -
Comparison of
(18)
F-NaF Imaging,
(99m)
Tc-MDP Scintigraphy, and
(18)
F-FDG for Detecting Bone Metastases
por: Dadgar, Habibollah, et al.
Publicado: (2022)